News

News
Partner news

Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

Read full story
Partner news

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

Read full story
Other news

Amgen to Acquire Rodeo Therapeutics Corporation

Read full story
Other news

Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Read full story
Other news

Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million

Read full story
Other news

FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use

Read full story
Other news

ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes

Read full story
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Other news

ViaCyte Appoints Michael Yang President and CEO and Provides Company Update

Read full story
Other news

Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Other news

4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic

Read full story
Other news

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Read full story